Research Options:

Week of Expected Pricing Pending
Company Name BIOLABMART INC.
Proposed Ticker N/A
CUSIP N/A
Business Description The Company is a startup preclinical stage biotechnology company engaged in developing solutions to combat neuro-degenerative diseases and neuronal injuries. The Company is working to develop what it believes to be a novel stem cell system to repair and regenerate neuronal damage.
Lead Underwriter N/A
Co-Managers N/A
Initial Shares 11,24,000
Revised Initial Shares N/A
Initial Price $00.25-$00.25
Revised Price N/A
Final Price N/A
Final Ticker N/A

 

 

   
  © 2024 ICE Data Services. All rights reserved.